NDAQ Stock Recent News

VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Versus Systems, Inc. (NASDAQ: VS) (the “Company”) announced today the execution of two significant agreements with Aspis Cyber Technologies, Inc. (“ASPIS”), a cloud-based mobile endpoint cybersecurity technology firm.

Denver, Oct. 15, 2024 (GLOBE NEWSWIRE) -- authID Inc.  (Nasdaq: AUID), a leading provider of secure identity verification and authentication solutions, today announced that the Compensation Committee of the Company approved the grant of options as an inducement to new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

To get the latest market news check out finance.yahoo.com US stocks closed lower on Tuesday as investors reacted to downbeat earnings from ASML Holding (ASML) that dropped a day earlier than expected, sending chipmaker stocks lower across the board. Shares of the leading semiconductor supplier sank more than 15% after its earnings, released in an apparent error, showed a disappointing sales outlook for 2025.

PLANO, Texas , Oct. 15, 2024 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications technology and IP optical networking solutions to many of the world's largest service providers, enterprises, and critical infrastructure operators to modernize and protect their networks, today announced that, in connection with his appointment as Chief Financial Officer, the Board of Directors has awarded John Townsend, as inducement awards, sign-on equity grants consisting of one time-based vesting grant of restricted share units ("RSUs") and two performance-based vesting grants of restricted share units ("PSUs").   Subject to Mr.

Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced today that a Nasdaq Hearings Panel (the “Panel”) has granted the Company's request for an extension of time to demonstrate compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq Stock Market LLC (“Nasdaq”) set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).

NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that on October 14, 2024, Seelos Therapeutics, Inc. (the "Company") received notice that the Nasdaq Hearings Panel (the "Panel") had determined to delist the Company's common stock from The Nasdaq Stock Market LLC ("Nasdaq") due to the Company's failure to comply with the minimum stockholder's equity requirement under Nasdaq Listing Rule 5550(b)(1) (the "Equity Standard Rule"). As previously disclosed, the Panel had provided the Company until October 11, 2024, to regain compliance with the Equity Standard Rule.

KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has entered into a definitive agreement for the purchase and sale of 1,633,987 shares of common stock at a purchase price of $3.06 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 4,551,019 shares of common stock at an exercise price of $3.06 per share.

Wall Street mood has become circumspect as traders gear up to receive a slew of earnings reports this week amid the market's record run. The Nasdaq Composite has been a laggard among the major averages and it remains to be seen if the early sentiment reverses and tech stocks could finish the session with a flourish.

Launched at the end of January, the NEOS Nasdaq 100 High Income ETF (QQQI) recently crossed $500 million in AUM. The fund remains a consistent performer within its category, offering high income and tax efficiency within the Nasdaq-100 Index.

At market open, key indexes are generally showing green. Shortly after 9:30 a.m.